E. Boldó

ORCID: 0000-0001-6866-9796
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hernia repair and management
  • Advanced Radiotherapy Techniques
  • Pelvic and Acetabular Injuries
  • Advances in Oncology and Radiotherapy
  • Breast Cancer Treatment Studies
  • Cutaneous Melanoma Detection and Management
  • Gallbladder and Bile Duct Disorders
  • Minimally Invasive Surgical Techniques
  • Intraperitoneal and Appendiceal Malignancies
  • Intestinal and Peritoneal Adhesions
  • Lung Cancer Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Industrial Vision Systems and Defect Detection
  • Bladder and Urothelial Cancer Treatments
  • Stoma care and complications
  • Surgical site infection prevention
  • Cardiac tumors and thrombi
  • Diagnosis and treatment of tuberculosis
  • Urinary and Genital Oncology Studies
  • Global Cancer Incidence and Screening
  • Infectious Diseases and Mycology
  • Testicular diseases and treatments
  • Nonmelanoma Skin Cancer Studies
  • melanin and skin pigmentation

Consorcio Hospitalario Provincial de Castellón
2006-2022

Universitat Jaume I
2021

Fundación Hospital Provincial de Castellón
2011-2014

Hospital de Sant Pau
1996-1997

Universitat Autònoma de Barcelona
1996

Abstract Background The French PRODIGE 7 trial, published on January 2021, has raised doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m 2 (30 minutes) for treatment of peritoneal metastases from colorectal cancer. However, several methodological flaws have been identified in 7, specially protocol or choice overall as main endpoint, so its results not assumed definitive, emphasizing need further research HIPEC. It seems that high-dose mytomicin-C (35 ) is...

10.1186/s12885-022-09572-7 article EN cc-by BMC Cancer 2022-05-12

10.1007/s00464-007-9587-z article EN Surgical Endoscopy 2007-10-17

Abstract The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and adjuvant chemotherapy. Tumor volume after a major prognostic factor these patients. ability to perform complete depends on the extent of disease skills surgical team. Several predictive models have been proposed evaluate possibility performing cytoreductive (CCS). External validation value three (Fagotti index R3 R4 models) predicting suboptimal (SCS) in AOC was performed this study. scores 3 were...

10.1038/s41598-021-86928-2 article EN cc-by Scientific Reports 2021-04-14

As the incidence of Malignant Melanoma (MM) reflects an interaction between skin colour and UV exposure, variations in genes implicated pigmentation tanning response to may be associated with susceptibility MM. In this study, 363 SNPs 65 gene regions belonging pathway have been successfully genotyped using a SNP array. Five hundred ninety MM cases 507 controls were analyzed discovery phase I. Ten candidate based on p-value threshold 0.01 identified. Two them, rs35414 (SLC45A2) rs2069398...

10.1371/journal.pone.0019271 article EN cc-by PLoS ONE 2011-04-29

A method consisting of the combination Synthetic Minority Over-Sampling TEchnique (SMOTE) and Sequential Forward Floating Selection (SFFS) technique is used to do band selection in a highly imbalanced, small size, two-class multispectral dataset melanoma non-melanoma lesions. The aim improve classification rate help identify those spectral bands that have more important role detection. All processing steps were designed taking into account low number samples dataset, situation quite common...

10.1364/boe.4.000514 article EN cc-by Biomedical Optics Express 2013-03-04

Melanoma of the anal region is a very uncommon disease, accounting for only 0.2-0.3% all melanoma cases. Mutations BRAF gene are usually absent in melanomas occurring this as well other sun-protected regions. The development tumour longstanding perianal fistula also extremely rare. More frequent case presenting fistula, that is, being consequence cancerous process, although we have found two cases fistula-generating reported literature. Here report 38-year-old male who presented with four...

10.1186/1471-2407-11-343 article EN cc-by BMC Cancer 2011-08-09

Besides more common sites such as lung or peritoneum, hepatocellular carcinoma (HCC) can metastatize to rare sites. We report herein a new metastatic site of HCC: the nail-bed. also review other recently reported HCC metastases (RSHM).A 66-year-old woman with 12-year history resected-stage IA who later presented lung, spleen and brain treated surgery, systemic therapies (sorafenib, sunitinib, capecitabine) radiotherapy. The patient was referred us because painful rapidly evolving mass in...

10.2147/jhc.s238963 article EN cc-by-nc Journal of Hepatocellular Carcinoma 2020-03-01

The early analysis of pigmented skin lesions is important for clinicians in order to recognize malignant melanoma. However, it difficult differentiate from benign due their similarity based on appearance. Since melanoma has a tendency grow inside the and depth penetration light into wavelength dependent, multispectral imaging acquisition processing approach classify as seems appropriate. This paper presents method diagnose over group 26 samples acquired with system, where 6 them are...

10.5220/0003843803860393 article EN 2012-01-01

Morbidity of open inguinal lymphadenectomy (OIL) is high. We use laparoscopy for pelvic time, preservation the greater saphenous vein and transverse incisions (laparoscopically assisted ilio-inguinal lymphadenectomy, LIIL) to improve postoperative outcomes.Retrospective comparison 14 patients who underwent LIIL seven OIL.Fourteen compared with OIL showed a statistically significant reduction in morbidity (15.3 vs 75%) hospital stay (7 15.7 days). Pelvic lymph node involvement (27%) was not...

10.2217/mmt-2019-0023 article EN cc-by-nc-nd Melanoma Management 2020-07-01
Coming Soon ...